Role Overview:
As an Associate Software Engineer – Full Stack Developer, you will be responsible for designing, developing, and maintaining software applications that meet business needs, ensuring system availability and performance. You will work closely with product managers, designers, and engineers to create scalable software solutions, automate operations, and respond to incidents to minimize downtime.
Roles & Responsibilities:
What We Expect from You:
The ideal candidate is a motivated, adaptable professional with a strong passion for problem-solving and continuous learning.
Basic Qualifications:
Must-Have Skills:
Good-to-Have Skills:
Soft Skills:
Education Requirement: Bachelor’s degree in Computer Science, IT, or related field (0 to 3 years of experience) OR Diploma with 4 to 7 years of relevant experience.
Technical Skills Required: Full Stack Software Development, Python, JavaScript, SQL, NoSQL, API Integration, Serverless, Microservices Architecture, Web Development, Version Control (Git), Agile, Scrum, Cloud Platforms (AWS, GCP, Azure), Docker, Kubernetes, Grafana, Databricks
Why Amgen?
At Amgen, you’ll have the opportunity to work with groundbreaking technologies, tackle challenging problems, and be part of a team making a real difference in patients’ lives. Join us and transform both the lives of patients and your career. Apply now!
Amgen Inc. is one of the world’s largest independent biotechnology companies, founded in 1980 and headquartered in Thousand Oaks, California. Amgen’s mission is to serve patients by using science and innovation to dramatically improve people’s lives. The company focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics, particularly in the areas of oncology, nephrology, cardiology, and inflammation.
With over 25,000 employees worldwide, Amgen is recognized for its robust pipeline and portfolio of biologic medicines, including well-known products such as Enbrel, Neulasta, and Repatha. The company is highly regarded for its commitment to scientific excellence and its leadership in biotechnology. In recent news, Amgen completed the acquisition of Horizon Therapeutics in 2023, significantly expanding its rare disease portfolio and reinforcing its position as a global biopharmaceutical leader.
Websiteamgen.com